Trials / Completed
CompletedNCT01457196
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,798 (actual)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective of this specimen correlative study is two-fold: to provide a mechanism for the association of known molecular alterations with clinical outcomes, and to provide rapid genetic profiling of alterations with known clinical utility using tumor and germline specimens to support treatment decisions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Tumor Genetic Sequencing | This study will look at genetic material from a sample of the subjects tumor, look at certain changes in the genetic material, and see if these changes are related to the subjects cancer. |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2018-06-06
- Completion
- 2018-06-06
- First posted
- 2011-10-21
- Last updated
- 2019-12-30
- Results posted
- 2019-12-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01457196. Inclusion in this directory is not an endorsement.